Showing results (1171-1180 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|September 21, 2014
Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBCHong Zhou, Khalid A Mohamedali, Ana Maria Gonzalez-Angulo, et al.
Molecular Cancer Therapeutics|September 21, 2014
Paclitaxel-loaded PEG-PE-based micellar nanopreparations targeted with tumor-specific landscape phage fusion protein enhance apoptosis and efficiently reduce tumorsTao Wang, Shenghong Yang, Leslie A Mei, et al.
Molecular Cancer Therapeutics|January 17, 2020
Extracellular Vesicle-Mediated In Vitro Transcribed mRNA Delivery for Treatment of HER2+ Breast Cancer Xenografts in Mice by Prodrug CB1954 without General ToxicityAlexis V Forterre, Jing-Hung Wang, Alain Delcayre, et al.
Molecular Cancer Therapeutics|November 18, 2020
Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor GrowthShauni Lien Geeraerts, Kim Rosalie Kampen, Gianmarco Rinaldi, et al.
Molecular Cancer Therapeutics|November 7, 2020
BRCA1/MAD2L1 Deficiency Disrupts the Spindle Assembly Checkpoint to Confer Vinorelbine Resistance in MesotheliomaSara Busacca, Laura O'Regan, Anita Singh, et al.
Molecular Cancer Therapeutics|November 12, 2020
Antibody Co-Administration Can Improve Systemic and Local Distribution of Antibody-Drug Conjugates to Increase In Vivo EfficacyJose F Ponte, Leanne Lanieri, Eshita Khera, et al.
Molecular Cancer Therapeutics|September 4, 2020
Menin-mediated Repression of Glycolysis in Combination with Autophagy Protects Colon Cancer Against Small-molecule EGFR InhibitorsBryson W Katona, Taylor Hojnacki, Rebecca A Glynn, et al.
Molecular Cancer Therapeutics|September 4, 2020
An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem CellsRuochen Dong, Ping Chen, Kishore Polireddy, et al.
Molecular Cancer Therapeutics|November 8, 2019
CRISPR Screening Identifies WEE1 as a Combination Target for Standard Chemotherapy in Malignant Pleural MesotheliomaDuo Xu, Shun-Qing Liang, Haitang Yang, et al.
Molecular Cancer Therapeutics|January 8, 2020
The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast CancerScott F Schoninger, Stacy W Blain
Pageof 599